Referred to the House Committee on Energy and Commerce.
This bill amends section 1903(a)(3)(E)(ii) of the Social Security Act to insert the phrase "renal medullary carcinoma, stroke" into the cited provision. The stated purpose is to provide incentives for education about the risk of renal medullary carcinoma to Medicaid beneficiaries who have sickle cell disease.
Progressives emphasize health equity and targeted outreach benefits.
Relative to its intended legislative type, this bill is a narrowly focused statutory amendment that clearly states its purpose but provides minimal operational, fiscal, or accountability detail.
This bill amends section 1903(a)(3)(E)(ii) of the Social Security Act to insert the phrase "renal medullary carcinoma, stroke" into the cited provision.
The stated purpose is to provide incentives for education about the risk of renal medullary carcinoma to Medicaid beneficiaries who have sickle cell disease.
The amendment applies to items and services furnished on or after the date of enactment.
Low-controversy, narrow technical fix that could clear committee and receive bipartisan support, but many similar small bills do not reach floor or are folded into larger packages.
Relative to its intended legislative type, this bill is a narrowly focused statutory amendment that clearly states its purpose but provides minimal operational, fiscal, or accountability detail.
Progressives emphasize health equity and targeted outreach benefits.
These are examples from the analysis, not a ranked list of the most-affected groups.
Progressives emphasize health equity and targeted outreach benefits.
Likely supportive: sees targeted education on a rare, aggressive cancer affecting many with sickle cell disease as a health-equity measure.
Views the change as a modest federal step to reduce disparities and improve early detection among a predominantly Black patient population.
Generally supportive if costs and implementation are reasonable.
Sees this as a narrowly targeted, low-cost public-health measure but wants clarity on how states will implement and be reimbursed.
Skeptical: identifies this as another federal expansion into Medicaid program details without clear funding.
Some conservatives may accept targeted awareness efforts, but many will worry about federal overreach and added administrative costs.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Low-controversy, narrow technical fix that could clear committee and receive bipartisan support, but many similar small bills do not reach floor or are folded into larger packages.
The bill has not accumulated any surfaced votes yet.
Progressives emphasize health equity and targeted outreach benefits.
Low-controversy, narrow technical fix that could clear committee and receive bipartisan support, but many similar small bills do not reach…
Relative to its intended legislative type, this bill is a narrowly focused statutory amendment that clearly states its purpose but provides minimal operational, fiscal, or accountability detail.
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.